Acepodia: Funding, Investors & Team (Oct 2026)
Acepodia is a biotech company in the clinical stage of development that focuses on creating cell therapies for cancer patients. They use their innovative Antibody-Cell Conjugation (ACC) technology to connect tumor-targeting antibodies to their own immune effector cells. By doing so, they are able to develop unique antibody cell effector (ACE) therapies that have a stronger connection to tumors with low levels of tumor antigens. Acepodia is composed of experienced leaders and scientific experts who are committed to advancing their pipeline of off-the-shelf ACE therapies. Their goal is to provide powerful and accessible cell therapies to a wide range of patients with solid tumors and blood cancers.
Acepodia has raised $100M across 1 funding round on record, the most recent a Series D of $100M announced in Jun 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Acepodia Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Acepodia Funding Rounds
Acepodia Founders and Leadership Team
No contact details are on record for this team yet.
Acepodia Funding Compared to Other Biotechnology Startups
Acepodia's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acepodia in Biotechnology and Alameda
Companies Similar to Acepodia
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Acepodia Funding FAQs
What does Acepodia do?
Acepodia is a biotech company in the clinical stage of development that focuses on creating cell therapies for cancer patients. They use their innovative Antibody-Cell Conjugation (ACC) technology to connect tumor-targeting antibodies to their own immune effector cells. By doing so, they are able to develop unique antibody cell effector (ACE) therapies that have a stronger connection to tumors with low levels of tumor antigens. Acepodia is composed of experienced leaders and scientific experts who are committed to advancing their pipeline of off-the-shelf ACE therapies. Their goal is to provide powerful and accessible cell therapies to a wide range of patients with solid tumors and blood cancers.
How much funding has Acepodia raised?
Acepodia has raised $100M across 1 round on record. The most recent is a Series D of $100M announced in Jun 2023.
When did Acepodia last raise funding?
Acepodia's most recent funding round on record is a Series D of $100M, announced in Jun 2023.
Who founded Acepodia?
FundedIQ lists Sonny Hsiao (Founder) at Acepodia.
Where is Acepodia headquartered?
Acepodia is based in Alameda, California, United States.
How many employees does Acepodia have?
Acepodia is in the 11-50 employee band.
How does Acepodia's funding compare to other Biotechnology startups?
Acepodia's latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Acepodia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acepodia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.